Human Molecular Genetics, 2001, Vol. 10, No. 7 693-698
© 2001 Oxford University Press
Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin
Emory University School of Medicine, Department of Pathology and Laboratory Medicine, Woodruff Memorial Research Building—Room 7105B, 1639 Pierce Drive, Atlanta, GA 30322, USA
Cancer cells exhibit a set of unique properties that distinguish them from their normal counterparts. Among these features are increased growth rates, loss of differentiation, escape from cell death pathways, evasion of anti-proliferative signals, a decreased reliance on exogenous growth factors and escape from replicative senescence. Acquisition of these features by malignant cells requires impairment of normal cellular control mechanisms. Over the past few years, it has become increasingly apparent that an important subset of the molecular changes commonly found in cancer cells involves inappropriate regulation of gene expression. This review will address regulatory pathways whose disruption contributes to the malignant phenotype. The failure to deacetylate and thus repress transcription by the Class I histone deacetylases HDAC1 and HDAC2 due to disruption of the Rb family of proteins has been firmly established as a mechanism leading to increases in growth rate and cellular proliferation. Recent data suggest that this regulatory circuit also executes G1 checkpoint arrest downstream of DNA damage, cellular senescence and contact inhibition. In contrast to this failure to deacetylate, it now seems probable that changes in differentiation status may result in part from inappropriate deacetylation and concomitant transcriptional repression mediated by the Class II histone deacetylases. This inappropriate deacetylation by HDAC4, HDAC5 and HDAC6 follows their relocalization from the cytoplasm to the nucleus. Thus, multiple classical features of cancer cells can be manifested by improper histone deacetylation.
+ Tel: +1 404 712 9666; Fax: +1 404 727 8540; Email: pwade@emory.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Noh, E. Y. Oh, J. Y. Seo, M. R. Yu, Y. O. Kim, H. Ha, and H. B. Lee Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-{beta}1-induced renal injury Am J Physiol Renal Physiol, September 1, 2009; 297(3): F729 - F739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Chou, D. Herman, and J. M. Gottesfeld Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases J. Biol. Chem., December 19, 2008; 283(51): 35402 - 35409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chavey, M. Muhlbauer, C. Bossard, A. Freund, S. Durand, C. Jorgensen, C. Jobin, and G. Lazennec Interleukin-8 Expression Is Regulated by Histone Deacetylases through the Nuclear Factor-{kappa}B Pathway in Breast Cancer Mol. Pharmacol., November 1, 2008; 74(5): 1359 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. de Bono, R. Kristeleit, A. Tolcher, P. Fong, S. Pacey, V. Karavasilis, M. Mita, H. Shaw, P. Workman, S. Kaye, et al. Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors Clin. Cancer Res., October 15, 2008; 14(20): 6663 - 6673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Granger, I. Abdullah, F. Huebner, A. Stout, T. Wang, T. Huebner, J. A. Epstein, and P. J. Gruber Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice FASEB J, October 1, 2008; 22(10): 3549 - 3560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Roque, E. Boncoeur, V. Saint-Criq, E. Bonvin, A. Clement, O. Tabary, and J. Jacquot Proinflammatory Effect of Sodium 4-Phenylbutyrate in {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator Lung Epithelial Cells: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2 and c-Jun-NH2-Terminal Kinase Signaling J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nian, B. Delage, J. T. Pinto, and R. H. Dashwood Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter Carcinogenesis, September 1, 2008; 29(9): 1816 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Datta, H. Kutay, M. W. Nasser, G. J. Nuovo, B. Wang, S. Majumder, C.-G. Liu, S. Volinia, C. M. Croce, T. D. Schmittgen, et al. Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis Cancer Res., July 1, 2008; 68(13): 5049 - 5058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Su, L. Altucci, and Q. You Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors Mol. Cancer Ther., May 1, 2008; 7(5): 1007 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Illi, C. D. Russo, C. Colussi, J. Rosati, M. Pallaoro, F. Spallotta, D. Rotili, S. Valente, G. Ragone, F. Martelli, et al. Nitric Oxide Modulates Chromatin Folding in Human Endothelial Cells via Protein Phosphatase 2A Activation and Class II Histone Deacetylases Nuclear Shuttling Circ. Res., January 4, 2008; 102(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Pruliere-Escabasse, C. Planes, E. Escudier, P. Fanen, A. Coste, and C. Clerici Modulation of Epithelial Sodium Channel Trafficking and Function by Sodium 4-Phenylbutyrate in Human Nasal Epithelial Cells J. Biol. Chem., November 23, 2007; 282(47): 34048 - 34057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Huh, J.-H. Ryu, and J.-S. Chun Regulation of Type II Collagen Expression by Histone Deacetylase in Articular Chondrocytes J. Biol. Chem., June 8, 2007; 282(23): 17123 - 17131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Nayagam, X. Wang, Y. C. Tan, A. Poulsen, K. C. Goh, T. Ng, H. Wang, H. Y. Song, B. Ni, M. Entzeroth, et al. SIRT1 Modulating Compounds from High-Throughput Screening as Anti-Inflammatory and Insulin-Sensitizing Agents J Biomol Screen, December 1, 2006; 11(8): 959 - 967. [Abstract] [PDF]
|
|
|
|
|
|
X. Li, S. Yin, Y. Meng, W. Sakr, and S. Sheng Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res., September 15, 2006; 66(18): 9323 - 9329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hrzenjak, F. Moinfar, M.-L. Kremser, B. Strohmeier, P. B. Staber, K. Zatloukal, and H. Denk Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol. Cancer Ther., September 1, 2006; 5(9): 2203 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Kulp, C.-S. Chen, D.-S. Wang, C.-Y. Chen, and C.-S. Chen Antitumor Effects of a Novel Phenylbutyrate-Based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5199 - 5206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Leong, J. R. Sloan, P. D. Nash, and G. L. Greene Recruitment of Histone Deacetylase 4 to the N-Terminal Region of Estrogen Receptor {alpha} Mol. Endocrinol., December 1, 2005; 19(12): 2930 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Acharya, A. Sparreboom, J. Venitz, and W. D. Figg Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review Mol. Pharmacol., October 1, 2005; 68(4): 917 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Puppin, F. D'Aurizio, A. V. D'Elia, L. Cesaratto, G. Tell, D. Russo, S. Filetti, E. Ferretti, E. Tosi, T. Mattei, et al. Effects of Histone Acetylation on Sodium Iodide Symporter Promoter and Expression of Thyroid-Specific Transcription Factors Endocrinology, September 1, 2005; 146(9): 3967 - 3974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, S. Yea, S. Li, Z. Chen, G. Narla, M. Banck, J. Laborda, S. Tan, J. M. Friedman, S. L. Friedman, et al. Kruppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1 J. Biol. Chem., July 22, 2005; 280(29): 26941 - 26952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Park, G. Y. Lee, J. E. Choi, H. G. Kang, J. S. Jang, S. I. Cha, E. B. Lee, S. G. Kim, C. H. Kim, W. K. Lee, et al. No Association between Polymorphisms in the Histone Deacetylase Genes and the Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1841 - 1843. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shen, J. Li, and P. Casaccia-Bonnefil Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain J. Cell Biol., May 23, 2005; 169(4): 577 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Wood, V. L. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects Physiol Genomics, February 10, 2005; 20(3): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, H. Yamashita, T. Toyama, H. Sugiura, Y. Omoto, Y. Ando, K. Mita, M. Hamaguchi, S.-i. Hayashi, and H. Iwase HDAC6 Expression Is Correlated with Better Survival in Breast Cancer Clin. Cancer Res., October 15, 2004; 10(20): 6962 - 6968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fukuoka, T. Fujii, J. H. Shih, T. Dracheva, D. Meerzaman, A. Player, K. Hong, S. Settnek, A. Gupta, K. Buetow, et al. Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer Clin. Cancer Res., July 1, 2004; 10(13): 4314 - 4324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Miao, I. G. Gonzalo, L. Lanting, and R. Natarajan In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions J. Biol. Chem., April 23, 2004; 279(17): 18091 - 18097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Brush, A. Guardiola, J. H. Connor, T.-P. Yao, and S. Shenolikar Deactylase Inhibitors Disrupt Cellular Complexes Containing Protein Phosphatases and Deacetylases J. Biol. Chem., February 27, 2004; 279(9): 7685 - 7691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Wright, P. L. Zeitlin, L. Cebotaru, S. E. Guggino, and W. B. Guggino Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins Physiol Genomics, January 15, 2004; 16(2): 204 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Kelly, M. Lemonnier, S. Zaffran, A. Munk, and M. E. Buckingham Cell history determines the maintenance of transcriptional differences between left and right ventricular cardiomyocytes in the developing mouse heart J. Cell Sci., December 15, 2003; 116(24): 5005 - 5013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, W. Xu, E. Bales, C. Colmenares, M. Conacci-Sorrell, S. Ishii, E. Stavnezer, J. Campisi, D. E. Fisher, A. Ben-Ze'ev, et al. SKI Activates Wnt/{beta}-Catenin Signaling in Human Melanoma Cancer Res., October 15, 2003; 63(20): 6626 - 6634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Hewitt, B. J. Deroo, K. Hansen, J. Collins, S. Grissom, C. A. Afshari, and K. S. Korach Estrogen Receptor-Dependent Genomic Responses in the Uterus Mirror the Biphasic Physiological Response to Estrogen Mol. Endocrinol., October 1, 2003; 17(10): 2070 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Scott and S. E. Plon Loss of Sin3/Rpd3 Histone Deacetylase Restores the DNA Damage Response in Checkpoint-Deficient Strains of Saccharomyces cerevisiae Mol. Cell. Biol., July 1, 2003; 23(13): 4522 - 4531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Berger, C. Bieniossek, C. Schaffitzel, M. Hassler, E. Santelli, and T. J. Richmond Direct Interaction of Ca2+/Calmodulin Inhibits Histone Deacetylase 5 Repressor Core Binding to Myocyte Enhancer Factor 2 J. Biol. Chem., May 9, 2003; 278(20): 17625 - 17635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fujita, S. Watanabe, T. Ichimura, Y. Ohkuma, T. Chiba, H. Saya, and M. Nakao MCAF Mediates MBD1-Dependent Transcriptional Repression Mol. Cell. Biol., April 15, 2003; 23(8): 2834 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bandyopadhyay, N. A. Okan, E. Bales, L. Nascimento, P. A. Cole, and E. E. Medrano Down-Regulation of p300/CBP Histone Acetyltransferase Activates a Senescence Checkpoint in Human Melanocytes Cancer Res., November 1, 2002; 62(21): 6231 - 6239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, M. Tan, M. Gosink, K. K. W. Wang, and Y. Sun Histone Deacetylase 5 Is Not a p53 Target Gene, But Its Overexpression Inhibits Tumor Cell Growth and Induces Apoptosis Cancer Res., May 1, 2002; 62(10): 2913 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yu, Z. S. Guo, M. G. Marcu, L. Neckers, D. M. Nguyen, G. A. Chen, and D. S. Schrump Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228 J Natl Cancer Inst, April 3, 2002; 94(7): 504 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chakraborty, V. Senyuk, S. Sitailo, Y. Chi, and G. Nucifora Interaction of EVI1 with cAMP-responsive Element-binding Protein-binding Protein (CBP) and p300/CBP-associated Factor (P/CAF) Results in Reversible Acetylation of EVI1 and in Co-localization in Nuclear Speckles J. Biol. Chem., November 21, 2001; 276(48): 44936 - 44943. [Abstract] [Full Text] [PDF]
|
|